A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials

ConditionParticipants Treated With Senza5

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-100

SponsorVittoria Biotherapeutics

About this trial

This is an open label, multi-center, long-term safety and efficacy follow-up trial for participants who have been treated with Senza5 CART5.

Eligibility criteria

Qualifiers

Provision of written informed consent by the participant or provision of written informed consent from the participant's parent[s]/legal guardian[s] and provision of assent from the participant, as applicable

Treated with Senza5 CART5 in a Vittoria BioTherapeutics sponsored clinical trial

Able to comply with trial requirements

Disqualifiers

There are no exclusion criteria.

Trial design

Treatments tested in this trial

Senza5 CART5

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Vittoria Biotherapeutics

Lead sponsor

Source ClinicalTrials.gov